Content and data provided by various third parties and Fidelity − Terms of Use | Help/Glossary
Research > ETFs > ETF / ETP Commentary > 

Use These ETFs as Health Stocks LLY, UNH, MRK Thrive

BY | ETF Database
6:19 am ET 07/17/26 | 14 VIEWS
Health stocks had a strong week, with some big firms seeing drugs approved. Eli Lilly (LLY) reportedly neared an agreement to acquire a psychedelics company. United Health Group (UNH) produced a massive earnings beat, appeasing analysts. Meanwhile, Merck (MRK) had a major cholesterol pill approved, as well. ETFs can provide powerful tools to get exposure to some of those names in one place.Key Takeaways: LLY, UNH, and MRK have all seen good news recently, inviting investors to use healthcare ETFs for exposure. The ETFs PPH, VHF, and XLV all offer exposure to names like the above, with each providing solid returns around about 25% over the last 12 months. Looking ahead, the three funds could help investors get exposure to that good news and diversify away from AI hyperscalers. LLY’s move to buy psychedelic drug shop AtaiBeckley, for example, has helped boost its stock notably. It is up more than 8% YTD. Meanwhile, UNH’s big earnings have helped it return 25.8% YTD and 3.8% over the last month. Finally, MRK’s big pill approval saw it spike 3.27% on July 16, and 19.9% YTD. The VanEck Pharmaceutical ETF (PPH A-) offers exposure to several names, including LLY and MRK. The strategy charges a 36-basis points (bps) fee to track the MVIS US Listed Pharmaceutical 25 index. The strategy offers specific targeted exposure to pharma, rather than health stocks writ large. PPH has returned 26.6% over the last 12 months.  Other funds to watch include, for example, the Vanguard Health Care ETF (VHT A+) which includes all of MRK, LLY, and UNH. VHT charges a nine-bps fee to track the MSCI US IMI 25/50 Health Care index. The fund has returned 24.4% over the last 12 months, per ETF Database data.  Finally, the State Street Health Care Select Sector SPDR ETF (XLV A) also offers exposure to all three of the stocks. Charging eight bps, the fund tracks the S&P Health Care Select Sector index. In doing so, it has returned 21.5% over the last 12 months.  See more: The ETF World Cup: How the Final 4 Single-Nation ETFs Stack Up Together, those types of healthcare ETFs can be efficient, flexible tools to get exposure to firms like these as they spike. Especially as AI supercharges innovation and markets anticipate rate cuts potentially next year, health care and healthcare innovation can intrigue.  For more news, information, and analysis, visit the Equity ETF Content Hub.

More Commentary

The Structured Credit Advantage: High Yields, Low Defaults
BY | ETF Database
7:02 am ET 07/17/26 | 7 VIEWS
Single-Country Swagger: Capture Localized Alpha With These ETFs
BY | ETF Database
5:19 am ET 07/17/26 | 14 VIEWS
Active Healthcare Stocks ETF TMED Spiked in 1H
BY | ETF Database
6:43 am ET 07/17/26 | 8 VIEWS
View more Commentary

Search Commentary

Enter Keyword(s)
Filter Results

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.